The News-Press and Naples Daily News asked Kodiak Hengstebeck of the FWC 10 questions about this year's Python Challenge.

AI agents such as OpenClaw are turning developer workstations into always-on edge servers. We test whether the Dell Pro Max ...

The malware program has been deployed across multiple sectors since April, helping to provide initial access sold to ransomware gangs.

When it comes to navigating your computer’s operating system, many users rely on graphical user interfaces (GUIs), but there’s an incredibly powerful tool sitting right under the hood: the Command ...

Cuba rejects US claims, says GAESA aids economic development Blue Diamond, Iberostar sever ties with GAESA hotels after expanded US sanctions Shipping firms and airlines suspend Cuba operations, ...

We’ve all been there—that moment when you realize you’re in way over your head. For me, it happened during my first briefing with a smart light vendor, when it became painfully obvious that I couldn’t ...

Many people are turning to artificial intelligence for personal finance advice. Writing a good AI prompt can mean the difference between receiving a reasonable or poor output, experts said. While AI ...

SNC’s site for E-4C work in Dayton, Ohio, has rapidly grown since the company won the competition in 2024. Credit: SNC The future backbone of U.S. nuclear command and control is taking shape in a set ...

Something to look forward to: Microsoft released new Windows 11 Insider Preview builds to the Canary, Dev, and Beta channels this week, bringing multiple new features for developers and power users.

These are the signs it’s time for a new pair. Ask Well These are the signs it’s time for a new pair. Credit...Eric Helgas for The New York Times Supported by By Allessandra DiCorato Q: I’ve heard a ...

AI success depends on whether enterprise data is ready, reachable, and close enough to the workloads that need it. In this eSpeaks episode, Dell Technologies’ Vrashank Jain explains why fragmented ...

Two new cancer cases have prompted Kyowa Kirin to shutter all clinical studies of its investigational anti-OX40 monoclonal antibody designed to treat inflammatory diseases. The discontinuation will ...